Ozonated water improves lipopolysaccharide-induced responses of an odontoblast-like cell line

J Endod. 2009 May;35(5):668-72. doi: 10.1016/j.joen.2009.01.016.

Abstract

Introduction: It is important to develop an antimicrobial agent without any damage on dental pulp. In the present study, we examined whether pretreatment of bacterial lipopolysaccharides (LPS) with ozonated water (O(3)aq) improves LPS-induced responses of rat odontoblastic cell line, KN-3.

Methods: After the pretreatment of LPS with O(3)aq, effects of LPS and O(3)aq-treated LPS on cell viability; calcification ability; expression of cyclooxygenase 2 (COX-2), interleukin 6 (IL-6), and tumor necrosis factor alpha (TNF-alpha); and activation of p38 of KN-3 cells were examined.

Results: The formation of mineralized nodules by KN-3 cells was suppressed by LPS, whereas that suppression was inhibited by the pretreatment of LPS with ozonated water. We also found that LPS-induced expression of COX-2, IL-6, and TNF-alpha and p38 activation were markedly suppressed when LPS was pretreated with ozonated water. Furthermore, expression of COX-2, IL-6, and TNF-alpha by LPS were mainly induced through p38 activation.

Conclusion: These results suggest that odontoblastic cells exhibit inflammatory responses against LPS and that ozonated water has the ability to improve LPS-induced inflammatory responses and suppression of odontoblastic properties of KN-3 cells through direct inhibition of LPS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aggregatibacter actinomycetemcomitans
  • Animals
  • Anti-Infective Agents / pharmacology*
  • Butadienes / pharmacology
  • Calcification, Physiologic / drug effects
  • Cell Line
  • Cell Survival / drug effects
  • Cyclooxygenase 1 / drug effects
  • Cyclooxygenase 2 / drug effects
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Escherichia coli
  • Imidazoles / pharmacology
  • Interleukin-6 / analysis
  • Lipid A / antagonists & inhibitors
  • Lipopolysaccharides / antagonists & inhibitors*
  • Membrane Proteins / drug effects
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • Mitogen-Activated Protein Kinases / drug effects
  • Nitriles / pharmacology
  • Odontoblasts / drug effects*
  • Oxidants, Photochemical / pharmacology*
  • Ozone / pharmacology*
  • Phosphorylation / drug effects
  • Pyridines / pharmacology
  • Rats
  • Tumor Necrosis Factor-alpha / drug effects
  • p38 Mitogen-Activated Protein Kinases / antagonists & inhibitors
  • p38 Mitogen-Activated Protein Kinases / drug effects

Substances

  • Anti-Infective Agents
  • Butadienes
  • Enzyme Inhibitors
  • Imidazoles
  • Interleukin-6
  • Lipid A
  • Lipopolysaccharides
  • Membrane Proteins
  • Nitriles
  • Oxidants, Photochemical
  • Pyridines
  • Tumor Necrosis Factor-alpha
  • U 0126
  • Ozone
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • Ptgs1 protein, rat
  • Ptgs2 protein, rat
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • SB 203580